WHO ICTRP trial
A Subcutaneous Dose Ranging Study of KY1005 in Patients with Moderate to Severe…
EUCTR2021-000725-28-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-000725-28-ES |
|---|---|
| Public title | A Subcutaneous Dose Ranging Study of KY1005 in Patients with Moderate to Severe Atopic Dermatitis |
| Scientific title | A Phase IIb, Randomised, Double Blind, Placebo Controlled, Parallel Group, Multicentre Dose Ranging Study of a Subcutaneous Anti-OX40L Monoclonal Antibody (KY1005) in Moderate to Severe Atopic Dermatitis (Study Testing Response Effect of KY1005 Against Moderate to Severe Atopic Dermatitis. The… |
| Primary sponsor | Kymab Limited |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Czechia;Hungary;Taiwan;Canada;Poland;Spain;Australia;Bulgaria;Germany;United Kingdom;Japan |
| Conditions | Atopic dermatitis MedDRA version: 21.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] |
| Interventions | Product Name: KY1005 Product Code: SAR445229 Pharmaceutical Form: Solution for injection INN or Proposed INN: amlitelimab CAS Number: 2378692-15-8 Current Sponsor code: KY1005 and SAR445229 Other descriptive name: KY1005 is a human… |
| Registration date | Feb 11, 2021 |
| Target size | 350 |
| Secondary IDs | KY1005-CT05_(DRI17366) |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: